Increased Plasminogen Activator Inhibitor-1, Decreased Tissue Factor Pathway Inhibitor, and Unchanged Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients With Primary Hyperparathyroidism
European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-09-0069
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2009
Authors
Publisher
Bioscientifica